Authors:
Perrin, S
Warchol, M
Grill, JP
Schneider, F
Citation: S. Perrin et al., Fermentations of fructo-oligosaccharides and their components by Bifidobacterium infantis ATCC 15697 on batch culture in semi-synthetic medium, J APPL MICR, 90(6), 2001, pp. 859-865
Authors:
Grill, JP
Cayuela, C
Antoine, JM
Schneider, F
Citation: Jp. Grill et al., Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance, J APPL MICR, 89(4), 2000, pp. 553-563
Citation: S. Perrin et al., Effects of fructooligosaccharides and their monomeric components on bile salt resistance in three species of bifidobacteria, J APPL MICR, 88(6), 2000, pp. 968-974
Authors:
Weitz, JJ
Marschke, RF
Sloan, JA
Grill, JP
Jett, JR
Knost, JA
Hatfield, AK
Zenk, DW
Bate, WW
Schaefer, PL
Citation: Jj. Weitz et al., A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer, LUNG CANC, 28(2), 2000, pp. 157-162
Citation: Wl. Miller et al., Improved survival after acute myocardial infarction in patients with advanced Killip class, CLIN CARD, 23(10), 2000, pp. 751-758
Citation: Jp. Grill et al., Bile salt toxicity to some bifidobacteria strains: Role of conjugated bilesalt hydrolase and pH, CAN J MICRO, 46(10), 2000, pp. 878-884
Authors:
Sgura, FA
Kopecky, SL
Grill, JP
Gibbons, RJ
Citation: Fa. Sgura et al., Supine exercise capacity identifies patients at low risk for perioperativecardiovascular events and predicts long-term survival, AM J MED, 108(4), 2000, pp. 334-336
Authors:
Kirschling, RJ
Grill, JP
Marks, RS
Kugler, JW
Gerstner, JB
Kuross, SA
Michalak, JC
Windschitl, HE
Krewer, KD
Jett, JR
Citation: Rj. Kirschling et al., Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group, AM J CL ONC, 22(5), 1999, pp. 517-522
Authors:
Marschke, RF
Grill, JP
Sloan, JA
Wender, DB
Levitt, R
Mailliard, JA
Gerstner, JB
Ghosh, C
Morton, RF
Jett, JR
Citation: Rf. Marschke et al., Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer, AM J CL ONC, 22(1), 1999, pp. 15-17